Wire Stories
-
1.1KWhat Kind of Marvelous Mountains and Rivers in Guang’an Produce Such Great Men Like Deng Xiaoping?
GUANG’AN, China–(BUSINESS WIRE)–Located in the east of Sichuan Province and adjacent to Chongqing, Dazhou and Nanchong, Guang’an is considered as the hub...
-
612
DEXLEVO’s Liquid Polymer Filler Raises KRW 26 Billion in Pre-IPO Funding
Valuation increased six times compared to Series B round in 2018� to use the proceeds to expand cGMP facility and accelerate brand...
-
577
The Korea Tourism Organization, Showcasing Korea�s Local Strength! Experience the Metaverse! The K-VIBE CONCERT Brings the Metaverse to Life Through Extended Reality
– Korea�s first ever metaverse concert, through ZEPETO Live – – HAHAHOHO Gyeongju World, where the cultural heritage of the Silla Dynasty...
-
611
GS Wealth Issues Open Letter to Luckin Coffee�s Shareholders and Convertible Bondholders
Raises Concerns that Luckin�s Board is Seeking to Assist Centurium Capital in its Attempt to Take Voting Control Urges Shareholders and Convertible...
-
554
Toyoda Gosei Develops Full Color LED Vehicle Interior Lamps
Interior lighting accentuates the attractiveness of interior form and materials KIYOSU, Japan–(BUSINESS WIRE)–Toyoda Gosei Co., Ltd. (TOKYO:7282) has developed full color LED...
-
537
Seoul Viosys Provides Air Purifier Sterilizers, Which Dramatically Reduce the Risk of COVID-19 Infection, to 300 Small Businesses in Korea for Free
Seoul Viosys donates air purifying sterilizers and plays an important role in K-quarantine People have the right to breathe clean air as...
-
599
BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT� (Siltuximab for Injection) in China for Idiopathic Multicentric Castleman Disease
CAMBRIDGE, Mass. & BEIJING & HEMEL HEMPSTEAD, England–(BUSINESS WIRE)–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160) and EUSA Pharma (UK), Ltd. today announced that...
-
667
BeiGene Announces Inclusion in the China National Reimbursement Drug List (NRDL) of Tislelizumab in Three New Indications, BRUKINSA� (Zanubrutinib) in One New Indication, and the First Listing for Pamiparib
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–BeiGene (NASDAQ:BGNE; HKEX:06160), a global science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment...
-
563
BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT� (Siltuximab for Injection) in China for Idiopathic Multicentric Castleman Disease
CAMBRIDGE, Mass. & BEIJING & HEMEL HEMPSTEAD, England–(BUSINESS WIRE)–BeiGene, Ltd. (NASDAQ:BGNE; HKEX:06160) and EUSA Pharma (UK), Ltd. today announced that the China...
-
694
Bluehole Publishes a Feature Story on China�s Recent Vaping Regulations
SHENZHEN, China–(BUSINESS WIRE)–China�s leading vaping media, Bluehole New Consumption, today published a feature story on recent vaping regulation updates in China. Here...
